Gibson Christopher sold RXRX
August 11, 2025 · Form 4 insider transaction
Gibson Christopher sold 500,300 shares of Recursion Pharmaceuticals, Inc. at $5.28 per share, a transaction worth $2.64M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
500,300
Price
$5.28
Total value
$2.64M
InsiderGibson Christopher
Role—
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateAugust 11, 2025
Filing dateAugust 13, 2025
Shares owned after1,004,619
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.